Studio City Enters into Senior Facilities Agreement
MACAU, Dec. 02, 2024 (GLOBE NEWSWIRE) — Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a […]
TSX News -
TC Energy provides conversion right and dividend rate notice for Series 1 and 2 preferred shares
CALGARY, Alberta, Dec. 02, 2024 (GLOBE NEWSWIRE) — News Release – TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) today announced […]
Lotus Technology Announces Delivery Updates of First Eleven Months of 2024
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus” or the “Company”), a leading global intelligent and […]
Azincourt Energy Grants RSUs
VANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) — AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSX.V: AAZ, OTC: AZURF), […]
Fountain Asset Corp. Closes Share for Debt Transaction
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) — FOUNTAIN ASSET CORP. (TSXV: FA) (the “Company”) is pleased to announce that it […]
TSX News -
Bombardier Confirms Reaching Settlement in Legal Dispute with Honeywell
MONTRÉAL, Dec. 02, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today confirmed that it has reached an agreement to settle […]
UPDATE — nCino to Participate in Upcoming Investor Conferences
WILMINGTON, N.C., Dec. 02, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today […]
BIP Investment Corporation Announces Results of Special Meeting and Intention to Redeem Series 1 Preferred Shares
BROOKFIELD, NEWS, Dec. 02, 2024 (GLOBE NEWSWIRE) — BIP Investment Corporation (“BIPIC”) (TSX: BIK.PR.A), an indirect subsidiary of Brookfield Infrastructure […]
Revolution Medicines Announces Commencement of Public Offering of Common Stock
REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
REDWOOD CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company […]
